Although the mechanisms by which FKN overexpression led to neuroprotection in a model of RP remains unknown, these results further support the viability of FKN as a therapeutic target and could have implications for other neurodegenerative diseases of the eye, including AMD, DR, and glaucoma. This evidence concerns the gene CX3CL1 and age-related macular degeneration.